Litcius/Paper detail

Enzyme-responsive micellar JQ1 induces enhanced BET protein inhibition and immunotherapy of malignant tumors

Zhenqi Zhang, Qiang Zhang, Jiguo Xie, Zhiyuan Zhong, Chao Deng

2021Biomaterials Science22 citationsDOI

Abstract

. In particular, when combined with radiotherapy, mJQ1 effectively suppressed tumor growth and brought about strong local and systemic antitumor immunity as evidenced by elevated CD8+ T cells and increased ratios of CD8+ T cells to Tregs, affording significantly improved survival of B16F10 tumor-bearing mice than their JQ1 counterparts and marked growth suppression of distant tumors. The great potency of enzyme-responsive micellar JQ1 makes it interesting for immunotherapy of various tumors.

Topics & Concepts

MelanomaCancer researchChemistryTumor microenvironmentIn vivoImmunotherapyGrowth inhibitionBromodomainCell growthDownregulation and upregulationPharmacologyCancerBiochemistryMedicineBiologyEpigeneticsTumor cellsInternal medicineBiotechnologyGeneProtein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsCAR-T cell therapy research
Enzyme-responsive micellar JQ1 induces enhanced BET protein inhibition and immunotherapy of malignant tumors | Litcius